Pieris Pharmaceuticals Inc
NASDAQ:PIRS
Operating Margin
Pieris Pharmaceuticals Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | US |
Market Cap | 13m USD |
Operating Margin |
-48%
|
Country | US |
Market Cap | 279.4B USD |
Operating Margin |
29%
|
Country | US |
Market Cap | 164.4B USD |
Operating Margin |
24%
|
Country | US |
Market Cap | 116.4B USD |
Operating Margin |
41%
|
Country | US |
Market Cap | 108.1B USD |
Operating Margin |
30%
|
Country | AU |
Market Cap | 135.7B AUD |
Operating Margin |
26%
|
Country | US |
Market Cap | 82.4B USD |
Operating Margin |
32%
|
Country | US |
Market Cap | 62.8B USD |
Operating Margin |
-100%
|
Country | US |
Market Cap | 43.1B USD |
Operating Margin |
-33%
|
Country | US |
Market Cap | 31.7B USD |
Operating Margin |
22%
|
Country | KR |
Market Cap | 37.2T KRW |
Operating Margin |
21%
|
Profitability Report
View the profitability report to see the full profitability analysis for Pieris Pharmaceuticals Inc.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Pieris Pharmaceuticals Inc's most recent financial statements, the company has Operating Margin of -47.8%.